1Cavallini G, Frulloni L. Somatostatin and octreotide in acute pancreatitis: the never-ending story[J]. Dig Liver Dis, 2001 ; 33(2):192-201.
2Nikou GC, Arnaoutis TP, Giamarellos-Bourboulis EJ,et al.The significance of the dosage adjustment of octreotide in the theatment of acute pancreatitis of moderate severity[J]. Hepatogastroenterology,2001 ; 2001 ;48(42): 1754-1757.
3Levy P, Hastier P, Arotcarena R, Bartolie E, et al. Efficacy of lanreotide 30mg on prevention of pain relapse after oral refeeding in patients with necrotizing acute pancreatitis. A phase Ⅱprospective multicentre study[J]. Pancreatology, 2004 ; 4 (3-4):229-232.
4Schein M, Ivatury R.Intra-abdominal hypertension and the abdominal compartment syndrome. Br J Surg,1998,85:1027-1028.
5Mcnelis J, Soffer S, Marini CP,et al. Abdominal compartment syndrome in the surgical intensive care unit. Am Surg,2002,68:18-23.
7Gecelter G, Fahoum B, Gardezi S,et al. Abdominal compartment syndrome in severe acute pancreatitis: an indication for a decompressing laparotomy? Dig Surg,2002,19:402-405.
8Pickhardt P, Shimony J, Heiken J,et al. The abdominal syndrome:CT findings. Am J Roentgenol,1999,173:575-579.
9Wang X,Wang B,Wu J,et al.Beneficial effects of growth hormone on bacterial translocation during the course of acute necrotizing pancreatitis in rats.Pancreas,2001,23:148-156.
10Wang X,Gong Z,Wu K,et al.Gastrointestinal dysmotility in patients with acute pancreatitis.J Gastroenterol Hepatol,2003,18:57-62.
